Cargando…
Impact of residual disease biomarkers on the prognosis of HER2‐positive breast cancer following neoadjuvant therapy
BACKGROUND: The changes in prognostic factors and clinicopathological characteristics of residual disease following neoadjuvant therapy (NAT) for breast cancer are important references for postoperative adjuvant therapy. The analyses of the relationship between the clinicopathological characteristic...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242303/ https://www.ncbi.nlm.nih.gov/pubmed/36951436 http://dx.doi.org/10.1002/cam4.5839 |